Envestnet, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of reconciliation of the numerators and denominators used in computing basic and diluted net income (loss) per share attributable to common stockholders

The following table provides the numerators and denominators used in computing basic and diluted net income (loss) per share attributable to Envestnet, Inc.:


	Three Months Ended
	March 31,
		2021		2020
		(in thousands, except share and per share data)







Net income (loss) attributable to Envestnet, Inc. - Basic (a)		$	14,946	$	(7,336)
Interest on dilutive Convertible Notes due 2025, net of tax		1,252		—
Net income (loss) attributable to Envestnet, Inc - Diluted (b)		$	16,198	$	(7,336)

Weighted-average common shares outstanding:
Basic (c)		54,208,469		53,016,511
Effect of dilutive shares:
Options to purchase common stock		222,387		—
Unvested restricted stock units		562,606		—
Convertible Notes due 2025		4,848,044		—
Warrants		76,142		—
Diluted (d)		59,917,648		53,016,511

Net income (loss) per share attributable to Envestnet, Inc common stock:
Basic (a/c)		$	0.28	$	(0.14)
Diluted (b/d)		$	0.27	$	(0.14)

Schedule of anti-dilutive securities excluded from computation of diluted earnings per share

Securities that were anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share were as follows:


	Three Months Ended
	March 31,
		2021	2020
Options to purchase common stock		—	785,399
Unvested RSUs and PSUs		—	2,074,757
Warrants		—	470,000
Convertible Notes due 2023		5,050,505	5,050,505
Total anti-dilutive securities		5,050,505	8,380,661